Monday, June 23, 2025 6/23/2025

FASEB's The Autoimmunity Conference

Award Number: R13AI161862
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2021
PERIOD OF PERFORMANCE END DATE: 06/30/2024

Group Awards By:

View Award Description

FASEB's The Autoimmunity Conference - PROJECT SUMMARY There has been enormous growth in the past few years in our understanding of pathogenic mechanisms in autoimmunity, and a new recognition of the similarities and important distinctions between different autoimmune diseases. Examples of rapidly moving areas of research in autoimmunity are the identification and characterization of subsets of pathogenic T and B cells that secrete unique inflammatory mediators and novel insights into the interface between genetic susceptibility, environmental stress, and the microbiome and metabolome. These findings have emerged largely from the work of basic scientists and the FASEB summer conference on Autoimmunity has historically focused on discussion of new findings in basic research. However, we believe that it is crucial for basic scientists to establish and maintain connections to scientists who are working to translate mechanisms into therapeutic targets. For example, the unexpected efficacy of therapeutic B cell depletion in some autoimmune diseases has prompted intense investigation by basic scientists into the role of B cells in pathogenic pathways. Likewise, the understanding of the role of the microbiome influencing immune regulation has led to the discussion and development of potentially novel therapeutic strategies for other illnesses, such as inflammatory bowel disease and rheumatoid arthritis. Basic information on metabolism in regulatory and effector T cells has spurred interest in the drive toward metabolic manipulations as therapeutic strategies, not only in cancer, but also in autoimmunity. Notably one of the major complications of cancer immunotherapy with checkpoint inhibitors is the development of a wide-range of autoimmune complications. Therefore, while maintaining a focus on cutting edge basic research in autoimmunity, we will continue to involve translational scientists that study mechanisms of tissue injury in human disease to discuss novel treatment strategies and data on the successes and failures of manipulating the immune system in autoimmune humans and cancer patients. We expect that emphasis on therapeutic treatment of autoimmune disease will attract both basic and industry scientists and will stimulate strong interest among both junior and established investigators. Our program combines a focus on diversity with an emphasis on involving and mentoring trainees at all levels. The size and setting of this meeting are ideal to promote the open exchange of data and cross-fertilization of ideas that will stimulate new hypotheses and attract more trainees into autoimmunity research.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$1,400 )
2025	2021	FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY	6120 EXECUTIVE BLVD STE 575	ROCKVILLE	MD	20852	MONTGOMERY	USA	Allergy and Infectious Diseases Research	000	1	11/30/2024	NEW	-$1,400
														Subtotal = -$1,400

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2021	FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY	6120 EXECUTIVE BLVD	ROCKVILLE	MD	20852	MONTGOMERY	USA	Allergy and Infectious Diseases Research	000	1	5/4/2023	NEW	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $10,000 )
2021	2021	FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY	9650 ROCKVILLE PIKE	BETHESDA	MD	20814	MONTGOMERY	USA	Allergy and Infectious Diseases Research	000	1	6/24/2021	NEW	$10,000
														Subtotal = $10,000

Grand Total All Awards = $8,600

Top

All Categories

About

Search

Reports

Data Submission

Award Information

FASEB's The Autoimmunity Conference

Award Number: R13AI161862

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2021

PERIOD OF PERFORMANCE END DATE: 06/30/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer